These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 498305)

  • 1. [Dependence of leukocyte migration inhibition on the progress and activity of gynecological tumours (author's transl)].
    Tosner J; Fixa B
    Cesk Gynekol; 1979 Sep; 44(8):587-91. PubMed ID: 498305
    [No Abstract]   [Full Text] [Related]  

  • 2. [Leukocyte migration inhibition in women with tumors in an environment with ovarian carcinoma antigen and encephalitogenic factor].
    Tosner J; Fixa B
    Cas Lek Cesk; 1984 Mar; 123(12):354-7. PubMed ID: 6085556
    [No Abstract]   [Full Text] [Related]  

  • 3. Leucocyte migration inhibition test in patients with gynaecologic malignancy.
    Tosner J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(4):415-89. PubMed ID: 6978511
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of the concentration and origin of antigens on leukocyte migration in women with malignant gynecologic tumors].
    Tosner J; Fixa B
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1980; 23(2):121-7. PubMed ID: 6969923
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of leucocyte migration in women with ovarian carcinoma, and its dependence on the quantity of lymphocytes forming E-rosettes (author's transl)].
    Tosner J; Vejbora O; Fixa B
    Cas Lek Cesk; 1981 Sep; 120(38):1150-4. PubMed ID: 7273087
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study about the use of LAI test and MI test in immunodiagnostics of gynecological tumours (author's transl)].
    Jandová A; Svec M; Heyberger K; Laurová L; Novotná J; Roubal J; Trnka V; Vancurik J
    Cesk Gynekol; 1979 Feb; 44(1):44-50. PubMed ID: 371825
    [No Abstract]   [Full Text] [Related]  

  • 8. [The influence of irradiation and chemotherapy on immunity of female patients with malignant tumour (author's transl)].
    Tosner J; Fixa B; Vrastilová P
    Cesk Gynekol; 1979 Nov; 44(9):662-7. PubMed ID: 509600
    [No Abstract]   [Full Text] [Related]  

  • 9. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Schmeisser G; Kademann J
    Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of ovarian carcinoma tissue culture in the leukocyte migration inhibition test].
    Tosner J; Fixa B; Jirkalová V; Donát J
    Cas Lek Cesk; 1987 Apr; 126(14):439-41. PubMed ID: 3581139
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
    Kochetkova VA
    Lab Delo; 1980; (12):744-6. PubMed ID: 6163894
    [No Abstract]   [Full Text] [Related]  

  • 12. [Leukocyte migration. Clinical study (author's transl)].
    Laurent P; Goudot-Patay B; Grozel JM
    Anesth Analg (Paris); 1979; 36(7-8):307-10. PubMed ID: 393135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell-mediated immunity in myoma uteri measured by the leukocyte migration inhibition test (author's transl)].
    Lunow E
    Zentralbl Gynakol; 1979; 101(8):515-22. PubMed ID: 463417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
    Tosner J; Fixa B
    Clin Exp Immunol; 1979 Nov; 38(2):356-60. PubMed ID: 527267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of immunosuppressive effect of measles virus. In vitro effect of the leukocyte migration inhibition test (author's transl)].
    Sakiyama Y
    Hokkaido Igaku Zasshi; 1980 Jul; 55(4):315-22. PubMed ID: 7009364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of estimation of ABH isoantigens in gynecological tumors (author's transl)].
    Tosner J
    Cesk Gynekol; 1981 Nov; 46(9):699-703. PubMed ID: 7307122
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the leucocyte migration inhibition test in cancer patients (author's transl)].
    Fujii M; Ohnoshi T; Kimura I
    Rinsho Byori; 1978 Feb; 26(2):169-72. PubMed ID: 633649
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H; Gleissenberger U
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attempts of checking up on the effects of treatment of gynecological cancer by means of the LAI test (author's transl)].
    Novotná J; Kobilková J; Laurová L; Jandová A; Vinglerová H; Coupek K; Skoda V; Motycka K
    Sb Lek; 1981; 83(11-12):326-31. PubMed ID: 7034144
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sensitization study of oncological patients to bacterial allergens with the aid of the leukocyte migration inhibition reaction].
    Kochetkova VA; Znamenskaia IN
    Vopr Onkol; 1981; 27(2):39-43. PubMed ID: 7210594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.